We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$69.6M
(+1.3%)
Cap. Flow
+$51.5M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TD Ameritrade Holding Corp
AMTD
|
+$41.7M |
| 2 |
LyondellBasell Industries
LYB
|
+$33.9M |
| 3 |
Brookfield
BN
|
+$27.6M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$21.4M |
| 5 |
Becton Dickinson
BDX
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Polaris
PII
|
+$36M |
| 2 |
T. Rowe Price
TROW
|
+$31.5M |
| 3 |
Elevance Health
ELV
|
+$27.8M |
| 4 |
ITC
ITC HOLDINGS CORP
ITC
|
+$26.5M |
| 5 |
Applied Materials
AMAT
|
+$24.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Financials | 18.2% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Technology | 11.08% |
| 5 | Industrials | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
Intercontinental Exchange
ICE
$89.5B
| $387K | 0.01% |
8,655
-2,535
| -23% | -$118K |
2013 Q4
6 quarters
|
|
|
DPLO
427
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $386K | 0.01% |
+8,635
| New | +$325K |
2015 Q2
0 quarters
|
|
428
CHS Inc Class B Series 4 Preferred Stock
CHSCL
$518M
| $379K | 0.01% |
14,000
+1,000
| +8% | +$27.6K |
2015 Q1
1 quarter
|
|
429
Banco Macro
BMA
$4.12B
| $376K | 0.01% |
8,238
+3,943
| +92% | +$209K |
2015 Q1
1 quarter
|
|
430
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.2B
| $375K | 0.01% |
3,475
+60
| +2% | +$6.58K |
2014 Q1
5 quarters
|
|
431
DELISTED
NuStar Energy L.P.
NS
| $373K | 0.01% |
6,287
-1,165
| -16% | -$73.7K |
2013 Q2
8 quarters
|
|
432
Vodafone
VOD
$37.6B
| $370K | 0.01% |
10,160
-1,742
| -15% | -$62.8K |
2013 Q2
8 quarters
|
|
433
J.M. Smucker
SJM
$13.7B
| $368K | 0.01% |
3,392
+30
| +0.9% | +$3.47K |
2014 Q1
5 quarters
|
|
|
PETX
434
DELISTED
Aratana Therapeutics, Inc.
PETX
| $368K | 0.01% |
24,329
+8,001
| +49% | +$116K |
2014 Q4
2 quarters
|
|
435
General Motors
GM
$74.9B
| $366K | 0.01% |
10,967
-156
| -1% | -$5.56K |
2015 Q1
1 quarter
|
|
436
NOV
NOV
$6.71B
| $366K | 0.01% |
7,576
-217
| -3% | -$11.2K |
2013 Q2
8 quarters
|
|
437
Constellation Brands
STZ
$22.2B
| $366K | 0.01% |
3,151
+166
| +6% | +$19.6K |
2013 Q2
8 quarters
|
|
438
Sabesp
SBS
$22B
| $357K | 0.01% |
355,630
+2,614
| +0.7% | +$2.94K |
2014 Q1
5 quarters
|
|
439
HP
HPQ
$27.5B
| $356K | 0.01% |
26,116
+51
| +0.2% | +$757 |
2013 Q4
6 quarters
|
|
440
Eversource Energy
ES
$25.2B
| $353K | 0.01% |
7,764
+1,296
| +20% | +$62.8K |
2014 Q4
2 quarters
|
|
441
Viatris
VTRS
$21.2B
| $349K | 0.01% |
5,140
+860
| +20% | +$60.8K |
2013 Q2
8 quarters
|
|
442
Core Laboratories
CLB
$456M
| $347K | 0.01% |
3,040
-120
| -4% | -$14.6K |
2013 Q2
8 quarters
|
|
443
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $347K | 0.01% |
4,668
+63
| +1% | +$4.67K |
2014 Q3
3 quarters
|
|
444
Xylem
XYL
$24.5B
| $341K | 0.01% |
9,197
+283
| +3% | +$10.3K |
2013 Q2
8 quarters
|
|
|
PNY
445
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $339K | 0.01% |
9,600
| – | – |
2013 Q2
8 quarters
|
|
|
CDK
446
DELISTED
CDK Global, Inc.
CDK
| $337K | 0.01% |
+6,234
| New | +$320K |
2015 Q2
0 quarters
|
|
447
Avery Dennison
AVY
$13.4B
| $336K | 0.01% |
5,508
+123
| +2% | +$7.15K |
2013 Q3
7 quarters
|
|
448
MetLife
MET
$64.9B
| $336K | 0.01% |
6,733
-35
| -0.5% | -$1.66K |
2013 Q4
6 quarters
|
|
449
DELISTED
Spectra Energy Corp Wi
SE
| $336K | 0.01% |
10,300
+100
| +1% | +$3.56K |
2013 Q2
8 quarters
|
|
450
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $335K | 0.01% |
37,580
+258
| +0.7% | +$3.02K |
2014 Q4
2 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
- Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
- Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
- Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
- Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
- Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.
Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.